Table 1.
Suppressive activity of CD4+CD25high Treg samples
| Samples | CD4+CD25high Treg suppressive activity |
|---|---|
| HD1 | 44.3% |
| HD2 | 44.1% |
| HD3 | 56.1% |
| PCa 1 | 44.0% |
| PCa 2 | 55.8% |
| PCa 3 | 51.7% |
Results are expressed as % of suppressive activity of CD4+CD25high Treg against the proliferation of CD4+CD25− effector T-cell.
HD = healthy donor; PCa = metastatic prostate cancer patient.